Detailed price information for Fennec Pharmaceuticals Inc (FRX-T) from The Globe and Mail including charting and trades.

In March 2024, Fennec entered into an exclusive licensing ... launches in other major European markets.” The data from two open-label, randomized Phase 3 trials, SIOPEL 6 (pivotal) and the ...

Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...

PEDMARQSI is the First and Only Approved Therapy in the EU and U.K. for the Prevention of Ototoxicity, or Hearing Loss, Induced by Cisplatin Chemotherapy in Patients 1 month to ~ Norgine Pharmaceutica ...

~ PEDMARQSI® (anhydrous sodium thiosulfate) is the first and only treatment available within NHS England and Wales for the prevention of cisplatin-induced ototoxicity (hearing loss) in children ...

Inc. (NASDAQ: FENC; TSX: FRX), a specialty pharmaceutical company with a market capitalization of $183 million, announced today that their partner, Norgine Pharmaceuticals Ltd., has launched PEDMARQSI ...

The animals of Critter Encounters Animal Sanctuary — everything from a lop-eared bunny to tarantulas and a pair of fennec ...

The two Proba-3 platforms remained attached together ... Proba-3’s journey to see the sun’s corona. Credit: ESA-Magic Fennec The mission will demonstrate this level of precision by creating ...

Up until now, old school characters from the original Star Wars trilogy had been banned from Black Spire Outpost by Walt ...